APOE and Alzheimer disease: These data demonstrated that BIG2 can serve as a molecular marker of early synaptic degeneration that is more sensitive than classic synaptic proteins, and BIG2 may be closely involved in the molecular mechanism underlying the promoting effect of APOE4 on synapse degeneration in AD.